We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SLS market cap is 46.49M. The company's latest EPS is USD -1.1646 and P/E is -1.25.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.15M | -9.45M | -11.28M | -9.05M | -9.36M |
| Net Income | -7.02M | -9.12M | -11.1M | -8.84M | -9.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.9M | 7.6M | 1M | 0 |
| Operating Income | -20.04M | -16.98M | -19.59M | -41.95M | -37.87M |
| Net Income | -27.95M | -16.76M | -20.7M | -41.3M | -37.34M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26M | 20.94M | 29.1M | 18.57M | 8.09M |
| Total Liabilities | 13.4M | 16.09M | 15.94M | 13.72M | 11.91M |
| Total Equity | 12.6M | 4.85M | 13.17M | 4.84M | -3.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.61M | 46.05M | 26.28M | 20.94M | 6.22M |
| Total Liabilities | 10.52M | 18.09M | 5.93M | 16.09M | 14.2M |
| Total Equity | 6.09M | 27.96M | 20.35M | 4.85M | -7.98M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.66M | -23.81M | -12.13M | -19.69M | -26.59M |
| Investing | -4.5M | -4.5M | N/A | -2.5M | -5.5M |
| Financing | 23.15M | 24.08M | 18.9M | 18.88M | 18.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.64M | -10.42M | -26.02M | -23.81M | -31.41M |
| Investing | N/A | N/A | N/A | -4.5M | -5.5M |
| Financing | 19.57M | 38.44M | 12.07M | 24.08M | 22.32M |
| Market Cap | 46.49M |
| Price to Earnings Ratio | -1.25 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 18.38 |
| Price to Book Ratio | -5.83 |
| Dividend Yield | - |
| Shares Outstanding | 32.06M |
| Average Volume (1 week) | 1.47M |
| Average Volume (1 Month) | 1.46M |
| 52 Week Change | 3.57% |
| 52 Week High | 1.914 |
| 52 Week Low | 0.4986 |
| Spread (Intraday) | 0.02 (1.37%) |
| Company Name | SELLAS Life Sciences Group Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sellaslifesciences.com/home/default.aspx |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
